Shunichi Kumagai

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Aqueous Solution

Systemic Sclerosis

Pulmonary Hypertension

Top Venues

International journal of rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Katsuhiko Yoneda, Soshi Takahashi, Kazuhiko Nakayama, Masanori Iwahashi, Noriaki Emoto, Shunichi Kumagai
Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis. International journal of rheumatic diseases (2023)
Katsuhiko Yoneda, Soshi Takahashi, Kazuhiko Nakayama, Masanori Iwahashi, Noriaki Emoto, Shunichi Kumagai
Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis. International journal of rheumatic diseases 26 (3) (2023)
Katsuhiko Yoneda, Soshi Takahashi, Kazuhiko Nakayama, Masanori Iwahashi, Noriaki Emoto, Shunichi Kumagai
Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis. International journal of rheumatic diseases 26 (3) (2023)
Ayano Mori, Toshiharu Saito, Miho Takahashi, Miho Shibata, Goh Tsuji, Saori Hatachi, Soshi Takahashi, Shunichi Kumagai
Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis. PloS one 15 (12) (2020)